Literature DB >> 17692263

[Association between asthma and viral infections].

J A Castro-Rodríguez1.   

Abstract

Viral respiratory infections are the factor most frequently associated with asthma (independently of phenotype, age, and phase of the natural history of asthma during which the infection occurs) and there is a strong temporal association between viral respiratory infections and acute obstructive/asthmatic episodes. Nevertheless, the role of viral infections in the pathogenesis of asthma remains poorly characterized. The factors that could explain this association are heterogeneous and sometimes contradictory. The four main causative mechanisms implicated in the association between viral respiratory infections and the subsequent development of asthma or wheezing in children are alterations in airway function and size, dysregulation (congenital and acquired) of airway tone, alterations in the immune response to infections, and the genetic variants involved in immune response. These mechanisms should be taken into account in future preventive and therapeutic strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17692263      PMCID: PMC7128541          DOI: 10.1016/s1695-4033(07)70578-7

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  64 in total

1.  Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study.

Authors:  L Bont; C J Heijnen; A Kavelaars; W M van Aalderen; F Brus; J T Draaisma; S M Geelen; J L Kimpen
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

2.  Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection.

Authors:  Meri Lahti; Johan Lofgren; Riita Marttila; Marjo Renko; Tuula Klaavuniemi; Ritva Haataja; Mika Ramet; Mikko Hallman
Journal:  Pediatr Res       Date:  2002-06       Impact factor: 3.756

3.  Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.

Authors:  D K Shay; R C Holman; G E Roosevelt; M J Clarke; L J Anderson
Journal:  J Infect Dis       Date:  2000-11-10       Impact factor: 5.226

4.  Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

Authors:  Nele Sigurs; Per M Gustafsson; Ragnar Bjarnason; Fredrik Lundberg; Susanne Schmidt; Fridrik Sigurbergsson; Bengt Kjellman
Journal:  Am J Respir Crit Care Med       Date:  2004-10-29       Impact factor: 21.405

5.  Lung function, pre- and post-natal smoke exposure, and wheezing in the first year of life.

Authors:  I B Tager; J P Hanrahan; T D Tosteson; R G Castile; R W Brown; S T Weiss; F E Speizer
Journal:  Am Rev Respir Dis       Date:  1993-04

6.  Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis.

Authors:  T Goetghebuer; K Isles; C Moore; A Thomson; D Kwiatkowski; J Hull
Journal:  Clin Exp Allergy       Date:  2004-05       Impact factor: 5.018

7.  The relationship between infant airway function, childhood airway responsiveness, and asthma.

Authors:  Stephen W Turner; Lyle J Palmer; Peter J Rye; Neil A Gibson; Parveenjeet K Judge; Moreen Cox; Sally Young; Jack Goldblatt; Louis I Landau; Peter N Le Souëf
Journal:  Am J Respir Crit Care Med       Date:  2004-02-05       Impact factor: 21.405

8.  Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness.

Authors:  O Einarsson; G P Geba; Z Zhu; M Landry; J A Elias
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

Review 9.  The effect of parental smoking on lung function and development during infancy.

Authors:  Janet Stocks; Carol Dezateux
Journal:  Respirology       Date:  2003-09       Impact factor: 6.424

10.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.

Authors:  Peter A B Wark; Sebastian L Johnston; Fabio Bucchieri; Robert Powell; Sarah Puddicombe; Vasile Laza-Stanca; Stephen T Holgate; Donna E Davies
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.